Sonic Healthcare Ltd

SHL: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
RWLOCK|ss@PhLOCK|^p!^^V

Sonic Healthcare Earnings: Solid Industry Outperformance and Margins Poised to Expand

Sonic's interim 2026 EBITDA rose 10% on 5% organic sales growth and underlying EBITDA margins up 30 basis points to 18%. Full-year EBITDA guidance of 8% growth at the midpoint in constant-currency was reaffirmed, and guided depreciation and interest expense was modestly lowered. Shares rallied 10%.

Sponsor Center